Attached files

file filename
10-K - FORM 10-K - ABERCROMBIE & FITCH CO /DE/l38903e10vk.htm
EX-23.1 - EX-23.1 - ABERCROMBIE & FITCH CO /DE/l38903exv23w1.htm
EX-21.1 - EX-21.1 - ABERCROMBIE & FITCH CO /DE/l38903exv21w1.htm
EX-32.1 - EX-32.1 - ABERCROMBIE & FITCH CO /DE/l38903exv32w1.htm
EX-24.1 - EX-24.1 - ABERCROMBIE & FITCH CO /DE/l38903exv24w1.htm
EX-31.1 - EX-31.1 - ABERCROMBIE & FITCH CO /DE/l38903exv31w1.htm
EX-31.2 - EX-31.2 - ABERCROMBIE & FITCH CO /DE/l38903exv31w2.htm
Exhibit 12.1
ABERCROMBIE & FITCH CO.
Computation of Leverage Ratio and Coverage Ratio
         
    Fiscal Year Ended
    January 30, 2010
Leverage Ratio Calculation:
       
Adjusted Total Debt (1)
    1,999,335  
Consolidated EBITDAR (2)
    677,692  
 
       
Leverage Ratio
    2.95  
 
       
 
       
Coverage Ratio Calculation:
       
Consolidated EBITDAR (2)
    677,692  
Net Interest Expense + Long-
       
Term Debt due in One Year +
       
Minimum Rent + Contingent Rent
    323,111  
 
       
Coverage Ratio
    2.10  
 
       
 
(1)   Adjusted Total Debt includes long-term debt, outstanding standby letters of credit and 600% of forward minimum rent commitments.
 
(2)   Consolidated EBITDAR” means, for any period, Consolidated Net Income for such period; plus without duplication and to the extent deducted in determining such Consolidated Net Income, the sum of (i) Interest Expense, (ii) income and franchise (or similar) tax expense, (iii) depreciation and amortization expense (including impairment of long term store fixed assets), (iv) Minimum Rent (plus contingent store rent plus non-cash rent expense), (v) Non-Cash Compensation Charges, (vi) losses on any Specified Auction Rate Securities, in each case not to exceed the applicable Temporary Impairment for such Specified Auction Rate Securities, (vii) non-cash charges related to the Ruehl Exit in an aggregate amount not to exceed $50,000,000, (viii) non-recurring cash charges in an aggregate amount not to exceed $61,000,000 related to the Ruehl Exit, (ix) additional non-recurring non-cash charges in an amount not to exceed $20,000,000 in the aggregate during any Testing Period, and (x) other non-recurring cash charges in an amount not to exceed $10,000,000 in the aggregate during any Testing Period minus without duplication (A) Interest Income, (B) any benefit received from income, franchise (or similar) tax expense to the extent included in the determination of Consolidated Net Income, (C) gains arising from any Specified Auction Rate Securities, in each case resulting from the excess of the Fair Value thereof and (D) any cash payments made during such period that were deducted in determining Consolidated Net Income and added back in determining Consolidated EBITDAR in a previous Testing Period under clauses (v) or (ix); all as determined in accordance with GAAP on a consolidated basis for the Parent and the Subsidiaries